Korean J Pain.  2023 Apr;36(2):147-148. 10.3344/kjp.23082.

The analgesic effect of programmed cell death protein-1

• Park JY

• KMID: 2541023
• DOI: http://doi.org/10.3344/kjp.23082

Reference

1. Su X, Wang B, Zhou Z, Li Z, Tong S, Chen S, et al. 2023; A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression. Korean J Pain. 36:60–71. DOI: 10.3344/kjp.22277. PMID: 36536517. PMCID: PMC9812689.

2. Zhao J, Roberts A, Wang Z, Savage J, Ji RR. 2021; Emerging role of PD-1 in the central nervous system and brain diseases. Neurosci Bull. 37:1188–202. DOI: 10.1007/s12264-021-00683-y. PMID: 33877518. PMCID: PMC8353059.

3. Chen G, Kim YH, Li H, Luo H, Liu DL, Zhang ZJ, et al. 2017; PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1. Nat Neurosci. 20:917–26. Erratum in: Nat Neurosci 2019; 22: 503. DOI: 10.1038/nn.4571. PMID: 28530662. PMCID: PMC5831162.

4. Jiang C, Wang Z, Donnelly CR, Wang K, Andriessen AS, Tao X, et al. 2020; PD-1 regulates GABAergic neurotransmission and GABA-mediated analgesia and anesthesia. iScience. 23:101570. DOI: 10.1016/j.isci.2020.101570. PMID: 33083737. PMCID: PMC7530307.

5. Syn NL, Teng MWL, Mok TSK, Soo RA. 2017; De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol. 18:e731–41. DOI: 10.1016/S1470-2045(17)30607-1. PMID: 29208439.

6. Makuku R, Khalili N, Razi S, Keshavarz-Fathi M, Rezaei N. 2021; Current and future perspectives of PD-1/PDL-1 blockade in cancer immunotherapy. J Immunol Res. 2021:6661406. DOI: 10.1155/2021/6661406. PMID: 33681388. PMCID: PMC7925068. PMID: 1ecccf248b544ac38986f344edc2ebbb.

7. Zhao S, Li F, Leak RK, Chen J, Hu X. 2014; Regulation of neuroinflammation through programed death-1/programed death ligand signaling in neurological disorders. Front Cell Neurosci. 8:271. DOI: 10.3389/fncel.2014.00271. PMID: 25232304. PMCID: PMC4153295. PMID: c05d7487adb1440ca17f9a323fc45ad1.

8. Liu BL, Cao QL, Zhao X, Liu HZ, Zhang YQ. 2020; Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia. JCI Insight. 5:e137386. DOI: 10.1172/jci.insight.137386. PMID: 32960817. PMCID: PMC7605531.

9. Wang Z, Jiang C, He Q, Matsuda M, Han Q, Wang K, et al. 2020; Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. Sci Transl Med. 12:eaaw6471. DOI: 10.1126/scitranslmed.aaw6471. PMID: 32075945. PMCID: PMC7536651.